Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
6.50
+0.04 (0.70%)
At close: Aug 1, 2025, 4:00 PM
6.48
-0.01 (-0.23%)
After-hours: Aug 1, 2025, 4:10 PM EDT

Revance Therapeutics Market Cap

Immatics has a market cap or net worth of $787.65 million as of August 1, 2025. Its market cap has decreased by -37.77% in one year.

Market Cap
787.65M
Enterprise Value
219.80M
1-Year Change
-37.77%
Ranking
Category
Stock Price
$6.50

Market Cap Chart

Since December 12, 2018, Immatics's market cap has increased from $172.50M to $787.65M, an increase of 356.61%. That is a compound annual growth rate of 25.69%.

History

DateMarket Cap% Change
Aug 1, 2025787.65M-7.19%
Dec 31, 2024848.62M-4.80%
Dec 29, 2023891.43M34.26%
Dec 30, 2022663.94M-21.47%
Dec 31, 2021845.50M24.56%
Dec 31, 2020678.78M263.23%
Dec 27, 2019 Pro Pro
Dec 31, 2018 Pro Pro
Dec 12, 2018 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition